Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.
about
Hepatitis C: a review for primary care physiciansPeginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis CGenetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4Outcomes of peginterferon alpha-2a and ribavirin hepatitis C therapy in Aboriginal CanadiansThe Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon TherapyEnhancing our understanding of current therapies for hepatitis C virus (HCV)The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in ChinaTreatment of hepatitis C virus genotype 4 with peginterferon alfa-2a: impact of bilharziasis and fibrosis stage.Meta-analysis: influence of host and viral factors in patients with chronic hepatitis C genotype 4 treated with pegylated interferon and ribavirin.Efficacy and safety of a novel pegylated interferon alpha-2a in Egyptian patients with genotype 4 chronic hepatitis COccult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapySustained virological response and its treatment predictors in hepatitis C virus genotype 4 compared to genotypes 1, 2, and 3: a meta-analysis.Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?Management of chronic hepatitis C: consensus guidelines.Chronic hepatitis C virus infection: genotyping and its clinical role.Safety and efficacy of Hansenula-derived PEGylated-interferon alpha-2a and ribavirin combination in chronic hepatitis C Egyptian childrenPegylated versus standard interferon plus ribavirin in chronic hepatitis C genotype 4: A systematic review and meta-analysis.Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment.Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues.Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.Characterization of full-length hepatitis C virus genotype 4 sequences.Clinical and pathological characteristics and response to combination therapy of genotype 4 chronic hepatitis C patients: experience from a spanish center.Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting.Challenge of hepatitis C in Egypt and hepatitis B in Mauritania
P2860
Q22306040-66297F5A-9905-4410-89C4-DFB58861D6A7Q24200189-445F3C8B-9B9C-4776-A3E6-795FAB3E328EQ27478102-3E93A9E6-9F62-4787-9510-FE4B2CC24F40Q27488260-619A8234-337F-40AF-8A1A-6BADACA5E45AQ27489040-06A24116-04D1-4B09-8A6D-7466B409E645Q28085718-69D94798-8B57-4587-A39B-0FF1BCCCEEB7Q28550281-B4BB36EE-BE32-444D-9E8D-00E63DEDAE66Q33869261-4EB8672B-6134-410E-A82E-1ABF3FA60903Q34270336-CE64FBDF-F23E-4810-93A5-4E30C1FCBCA9Q34286532-8686A7CA-E36C-44D2-86E4-8FCC9ACE49C4Q34387913-1B101B53-67B1-44CA-9399-56997B9A2E38Q36140466-5CCBAB8C-D361-4853-B6B0-8C4E9EE7006FQ36336416-958EDE96-2011-4F0C-AE5B-4A81435BB248Q36849347-0EF4A10F-ACF0-45A7-B478-4DBBD2853C87Q36895749-169EF3F4-CB12-47DC-A6BF-47A43AF17BBBQ37724686-B2ABC3E3-191D-4A6B-884A-3B8858468866Q38086264-7FB02983-BCD0-48C9-A0CD-86F600B35D99Q38121422-AB1B1F9A-567C-461E-AD7A-E5E02D3B5861Q38174246-2ED6A580-4D2B-4F06-8304-B2278617C8F0Q38224436-4007022F-72CF-4949-ACD5-401B43E06DA8Q43037234-5EF387B1-88CA-4553-8E8E-B2DAE157DBEFQ43040692-41B897F6-24F2-4B93-968D-AA006D63E125Q55263598-82059938-AA78-413C-B3AC-6FD9C7A11AE6Q57491236-857C05C0-6ECC-40AB-A472-BCB879A09007
P2860
Pegylated interferon-alpha 2b-ribavirin combination in Egyptian patients with genotype 4 chronic hepatitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pegylated interferon-alpha 2b- ...... genotype 4 chronic hepatitis.
@en
type
label
Pegylated interferon-alpha 2b- ...... genotype 4 chronic hepatitis.
@en
prefLabel
Pegylated interferon-alpha 2b- ...... genotype 4 chronic hepatitis.
@en
P2093
P2860
P1476
Pegylated interferon-alpha 2b- ...... genotype 4 chronic hepatitis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2893.2005.00604.X
P577
2005-07-01T00:00:00Z